| Variable | Measurement | Reference range |
| LDH | 478 | 313–618 U/L | Creatinine kinase | 40 | 55–170 | Cholesterol, total | 187 | <200 mg/dL | HDL | 28 | >40 mg/dL | LDL | 87 | <130 mg/dL | Cholesterol/HDL ratio | 6.7 | 0.0–4.9 | Triglycerides | 362 | <151 mg/dL | ESR | 26 | 1–13 mm/hr | CRP | Not checked | | ACE, before steroid treatment | 82 | 9–67 U/L | ACE, after steroid treatment | 24 | 9–67 U/L | Vit D, 25 hydroxy | 27.8 | 30–95 bng/mL | Vit D, 1,25 hydroxy, before steroid treatment | 79 | 18–72 pg/mL | Vit D, 1,25 hydroxy, after steroid treatment | 19 | 18–72 pg/mL | PTH, intact | 3.72 | 11–67 pg/mL | ANA | Negative | Negative | Immunofixation, serum | Polyclonal pattern | | IgG, serum | 1330 | 700–1600 mg/dL | IgA, serum | 187 | 70–400 mg/dL | IgM, serum | 44 | 40–230 mg/dL | Immunofixatin elec., urine | Polyclonal IGG and polyclonal light chains | | Protein, random urine | 10 | mg/dL | C3 | 119 | 90–180 mg/dL | C4 | 22 | 10–40 mg/dL | Quantiferon-Tb gold | Indeterminate | | Mitogen-nil | 0.16 | IU/ML | NIL | 0.03 | IU/ML | TB Ag-nil | 0 | IU/ML | ASO Ab | 46 | >200 IU/ML | ANCA vasculitides | | | Proteinase 3 Ab | <1.0 | <1.0 | Myeloperoxidase Ab | <1.0 | <1.0 | Hep A Ab, IgM | Nonreactive | Nonreactive | Hep A Ab, total | Reactive | Nonreactive | Hep B sAg | Negative | Negative | Hep B Core Ab, total | Reactive | Nonreactive | Hep BS ab | Reactive | Nonreactive | HepC Ab | Negative | Negative | HIV 1/2 Ab screen, rapid | Nonreactive | Nonreactive | HgbA1c | 6.9 | 4.2–5.9% | Urine culture | Negative | Negative | Urine chemistry | | | Protein, random urine | 21 | mg/dL | Microalbumin, random, urine | 2.4 | mg/dL | Sodium, random, urine | 105 | 30–90 mmol/L | Potassium, random, urine | 14.9 | mmol/L | Calcium, random, urine | 11.4 | mg/dL | Thyroxine, free | 0.61 | 0.8–1.5 ng/dL | TSH | 1.038 | 0.4–4.2 IU/mL | PSA free | 0.9 | ng/mL | PSA percent free | 43 | >25% | Total PSA | 2.1 |
≤4.0 |
|
|